MAPT and breast carcinoma: However, previous research also showed that neither overexpression nor depletion of tau modulates cellular sensitivity to taxanes and that it is unlikely to be a direct mechanism of taxane resistance in breast cancer [62], perhaps because binding between MAPs and microtubules is regulated by phosphorylation and other factors [55].